The market “Global
Intra-Uterine Contraceptive Devices Market” is expected to reach USD
4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5%in
the forecast period 2017 to 2024. The new market report contains data for
historic years 2015, the base year of calculation is 2016 and the forecast
period is 2017 to 2024.
For a Free Sample Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024
Intra-Uterine Contraceptive Devices
Market Categories: Segmentation
Global Intra-Uterine
Contraceptive Devices Market, By Product Type (Hormonal IUCD, Copper IUCD),
End-User (Hospitals, Gynaecology Clinics, Community Healthcare), Geography
(North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Intra-Uterine Contraceptive Devices
Market: Drivers
Some of the major factors
driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing
awareness of contraceptive, increased rate of unplanned pregnancies, rising
number of initiatives undertaken by the private firms, technological
advancementsand favourable insurance for IUCD’s.
INCREASED RATE OF UNPLANNED PREGNANCIES
Adolescents most commonly
use contraceptive methods with relatively high typical use failure rates such
as condoms, withdrawal, or oral contraceptive (OC) pills. Non-use, inconsistent
use, and use of methods with high typical use failure rates are reflected in
the high rate of unintended adolescent pregnancies in the U.S.
RISING NUMBER OF INITIATIVES UNDERTAKEN
BY THE PRIVATE FIRMS
The increasing number of
initiatives taken by the U.S. government has helped to limit the rising number
of unplanned pregnancies and abortions rate in the U.S. In addition, many
U.S.-based private firms also contribute towards the solutions for
pregnancy-related issues, which include maternal mortality, teenage
pregnancies, growing number of abortions, and so on, by promoting the use of
contraceptives, such as intrauterine contraceptive devices.
FAVOURABLE INSURANCE FOR IUCD’S
The insurance policy is
propelling the Global Intra-Uterine
Contraceptive Devices Market towards growth. In Finland, national insurance
covers acute but not preventive care, and contraceptives are usually paid by
the patient. In Sweden, the copper IUCDs are available free of cost, whereas
hormonal IUCDs are not. All FDA-approved contraceptives in the U.S. are covered
by insurance.
GROWING AWARENESS OF CONTRACEPTIVE
The need to avoid unwanted
pregnancies, especially among teenagers, is one of the major drivers for this
market. It has also been observed that for over half of the users also identify
non-contraceptive health benefits, such as treatment for excessive menstrual
bleeding, menstrual pain and acne, as reasons for use. This is also one of the
factors contributing to the growth of the market in Europe.
Inquiry
before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024
Intra-Uterine Contraceptive Devices Market:
Geographic Segmentation
·
North America
·
Europe
·
Asia-Pacific
·
South America
·
Rest of the World
Intra-Uterine Contraceptive Devices Market:
Company Share Analysis
Some of the major players
operating in this market are Bayer AG, Teva Pharmaceuticals Industries Ltd.,
Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon
Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA
and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd,
China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd,
Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble
International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com
Ltd, Bersil, Amed.
Read more about the Global
Intra-Uterine Contraceptive Devices Market visit @ http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024/
Table
of Content:
1. INTRODUCTION
2. RESEARCH
METHODOLOGY
2.2. ARRIVING AT THE INTRA-UTERINE
CONTRACEPTIVE DEVICES (IUCD) MARKET SIZE
2.3. GLOBAL INTRA-UTERINE CONTRACEPTIVE
DEVICESMARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.2.
RESTRAINTS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. HORMONAL IUCD (2013 – 2024)
6.3. COPPER IUCD (2013 – 2024)
7. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY
7.1. COUNTRYWISE INTRA-UTERINE CONTRACEPTIVE
DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER
BY COUNTRY)
7.1.1. NORTH AMERICA
7.1.2. EUROPE
7.1.3. ASIA-PACIFIC (APAC)
7.1.4. LATIN AMERICA
7.1.5. MIDDLE EAST AND AFRICA
7.2. KEY PRIMARY INSIGHTS: BY MAJOR
COUNTRIES
8. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: COMPETITIVE LANDSCAPE
8.1. GLOBAL IUCD MARKET: COMPANY SHARE
ANALYSIS
8.2. U.S.IUCD MARKET: COMPANY SHARE
ANALYSIS
8.3. EUROPE IUCD MARKET: COMPANY SHARE
ANALYSIS
8.4. APAC IUCD MARKET: COMPANY SHARE
ANALYSIS
8.5. SOUTH AMERICAIUCD MARKET: COMPANY
SHARE ANALYSIS
8.6. MIDDLE EAST AND AFRICA IUCD MARKET:
COMPANY SHARE ANALYSIS
8.7. MERGERS & ACQUISITIONS
8.8. NEW PRODUCT DEVELOPMENT &
APPROVALS
8.9. EXPANSIONS
8.10. REGULATORY CHANGES
8.11. PARTNERSHIP AND OTHER STRATEGIC
DEVELOPMENTS
9. GLOBAL INTRA-UTERINE
CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY PROFILES
9.1. BAYER HEALTHCARE AG
9.1.1 OVERVIEW
9.1.2 SWOT ANALYSIS
9.1.3 PRODUCT PORTFOLIO
9.1.4 REVENUE ANALYSIS
9.1.5 ANALYSTS VIEW
9.2. DKT INTERNATIONAL
9.2.1 OVERVIEW
9.2.2 SWOT ANALYSIS
9.2.3 PRODUCT PORTFOLIO
9.2.4 REVENUE ANALYSIS
9.2.5 ANALYSTS VIEW
9.3. TEVA PHARMACEUTICALS INDUSTRIES,
LTD
9.3.1 OVERVIEW
9.3.2 SWOT ANALYSIS
9.3.3 PRODUCT PORTFOLIO
9.3.4 REVENUE ANALYSIS
9.3.5 ANALYST VIEW
9.4. ALLERGEN, PLC
9.4.1 OVERVIEW
9.4.2 SWOT ANALYSIS
9.4.3 PRODUCT PORTFOLIO
9.4.4 REVENUE ANALYSIS
9.4.5 ANALYSTS VIEW
9.5. SMB CORPORATION
9.5.1
OVERVIEW
9.5.2 SWOT ANALYSIS
9.5.3 PRODUCT PORTFOLIO
9.5.4 REVENUE ANALYSIS
9.5.5 ANALYSTS VIEW
9.6. ACTAVIS PLC.
9.6.1 OVERVIEW
9.6.2
SWOT ANALYSIS
9.6.3 PRODUCT PORTFOLIO
9.6.4 REVENUE ANALYSIS
9.6.5 ANALYSTS VIEW
9.7 OCON MEDICAL LTD.
9.7.1 OVERVIEW
9.7.2 SWOT ANALYSIS
9.7.3 PRODUCT PORTFOLIO
9.7.4 REVENUE ANALYSIS
9.7.5 ANALYSTS VIEW
9.8
MONALISA NV
9.8.1 OVERVIEW
9.8.2 SWOT ANALYSIS
9.8.3 PRODUCT PORTFOLIO
9.8.4 REVENUE ANALYSIS
9.8.5 ANALYSTS VIEW
9.9
MEDISAFE DISTRIBUTION, INC.
9.9.1 OVERVIEW
9.9.2 SWOT ANALYSIS
9.9.3 PRODUCT PORTFOLIO
9.9.4 REVENUE ANALYSIS
9.9.5 ANALYSTS VIEW
9.10 MERIL LIFE SCIENCES PVT. LTD.
9.10.1 OVERVIEW
9.10.2 SWOT ANALYSIS
9.10.3 PRODUCT PORTFOLIO
9.10.4 REVENUE ANALYSIS
9.10.5 ANALYSTS VIEW
Related
Report
Europe
Injectable Drug Delivery Market – Industry Trends and Forecast to 2024
Europe Injectable Drug
Delivery Market By Type (Devices (Conventional Injection Devices, Self
Injection Devices), Formulations
(Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection
Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan
Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations,
Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs,
Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings,
Research Laboratories, Pharma & Biotech Companies), By Country (Germany,
France, U.K., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherland
and rest of Europe) – Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/medical-devices/drug-delivery-devices/europe-injectable-drug-delivery-market/
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Ankit
Singh
Data
Bridge Market Research
Tel:
+1-888-387-2818